MEDIFAST INC

MED

MEDIFAST INC

MED

Insider Sentiment (TTM):

Last Purchase:2026-05-11Last Sale:2024-03-08Shares Purchased (TTM):20,178Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:8,488,793Shares Outstanding:11,006,000Institutional Ownership Pct.:77.13%

Earnings Market Reaction:

Filing Date:2026-08-03Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	72	72	89	100	102	92	91	115	108	97	94	113
Available For Sale Securities Debt Securities Curr…	-	-	-	-	-	-	-	-	-	-	-	45
Inventory Net	21	21	20	23	30	39	42	40	40	46	55	58
Short Term Investments	98	97	78	74	61	73	71	55	55	59	56	-
Prepaid Taxes	5	5	5	4	5	-	0	8	9	5	9	-
Prepaid Expense And Other Assets Current	6	7	9	7	9	10	10	7	12	11	11	8
Assets Current	202	203	202	208	206	214	214	225	224	220	224	224
Property Plant And Equipment Net	28	30	31	33	35	36	38	39	40	51	51	53
Operating Lease Right Of Use Asset	24	13	7	8	9	10	11	12	13	15	16	16
Other Assets Noncurrent	6	7	8	7	8	9	10	11	12	14	15	16
Deferred Income Tax Assets Net	-	-	0	12	11	11	11	4	4	4	4	11
Assets	260	252	248	268	269	280	284	291	294	303	310	320
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	36	38	38	41	40	52	56	66	69	71	86	103
Taxes Payable Current	-	-	-	-	0	3	1	-	-	-	0	1
Accrued Income Taxes Current	-	-	0	0	-	-	1	-	-	-	-	-
Operating Lease Liability Current	5	4	5	5	6	6	6	6	6	6	6	5
Liabilities Current	42	42	43	47	46	61	64	72	75	77	92	110
Operating Lease Liability Noncurrent	22	12	6	7	7	8	10	12	13	15	16	17
Liabilities	64	54	49	54	53	69	74	84	88	92	108	127
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	43	41	40	38	37	35	33	31	30	28	27	24
Accumulated Other Comprehensive Income Loss Net Of…	0	0	0	0	0	0	0	0	0	0	0	0
Retained Earnings Accumulated Deficit	153	156	158	176	178	176	177	176	175	183	175	169
Stockholders Equity	196	198	199	215	216	211	210	207	205	211	201	193
Treasury Stock Common Value	-	-	-	-	-	-	-	-	-	-	0	0
Liabilities And Stockholders Equity	260	252	248	268	269	280	284	291	294	303	310	320
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	20	20	20	20	20	20	20	20	20	20	20	20
Common Stock Shares Issued	11	11	11	11	11	11	11	11	11	11	11	11
Shares Outstanding	11	11	11	11	11	11	11	11	11	11	11	11
Treasury Stock Common Shares	-	-	-	-	-	-	-	-	-	-	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	17.87%	-1.13%	-8.94%	-	-	-	-	-	-	-	-	-
2025	6.60%	12.32%	5.25%	3.85%	1.48%	-7.18%	-7.66%	-7.07%	1.43%	-10.93%	-6.85%	16.57%
2024	-35.71%	-43.59%	-47.51%	-12.27%	-7.72%	-16.49%	4.57%	-6.43%	-16.21%	-13.58%	-21.20%	-20.95%
2023	-	-	-	-12.58%	-20.49%	-26.09%	-3.33%	-4.87%	-21.84%	-25.18%	-35.60%	-48.93%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	4.86	4.80	4.69	4.45	4.47	3.52	3.34	3.11	2.98	2.84	2.43	2.04
Quick Ratio	4.21	4.13	4.01	3.81	3.62	2.72	2.53	2.46	2.29	2.10	1.72	1.43
Working Capital	160.47M	160.45M	158.72M	161.13M	160.26M	152.93M	150.24M	152.60M	149.14M	142.40M	131.73M	114.16M
Leverage & Debt
Debt to Equity	0.33	0.28	0.25	0.25	0.25	0.33	0.35	0.40	0.43	0.44	0.54	0.66
Interest Coverage TTM	-	-	-	-5.99	0.21	-1.77	0.60	2.16	7.24	20.76	44.32	80.95
Debt Ratio	0.25	0.22	0.20	0.20	0.20	0.25	0.26	0.29	0.30	0.30	0.35	0.40
Efficiency & Turnover
Asset Turnover TTM	1.20	1.30	1.45	1.54	1.71	1.87	2.03	2.21	2.52	2.88	3.42	3.77
Per Share Metrics
Diluted EPS TTM	-2.30	-1.82	-1.70	0.02	0.33	-0.64	0.19	0.67	2.68	6.18	9.10	10.97
Free Cash Flow Per Share TTM	0.36	-0.13	0.11	0.06	-0.22	1.23	1.56	3.09	4.97	7.76	12.97	16.00
Dividend Per Share TTM	0.02	0.01	0.02	0.02	0.02	0.02	0.07	1.71	3.36	5.00	6.71	6.70
Margin Metrics
Gross Profit Margin TTM	69.24%	70.12%	71.33%	72.44%	73.84%	73.89%	73.80%	73.80%	73.94%	73.15%	72.37%	71.25%
Operating Profit Margin TTM	-6.15%	-4.69%	-3.68%	-1.33%	0.10%	-1.16%	0.48%	1.61%	4.45%	9.00%	11.79%	12.34%
Net Profit Margin TTM	-8.08%	-5.78%	-4.84%	0.06%	0.76%	-1.29%	0.35%	1.09%	3.81%	7.55%	9.27%	9.84%
Growth Metrics
Net Revenue Growth (1Y)	-34.03%	-36.31%	-35.96%	-36.29%	-37.62%	-39.47%	-43.80%	-44.64%	-43.90%	-41.32%	-32.94%	-3.41%
Net Income Growth (1Y)	-803.93%	186.15%	-992.97%	-96.63%	-87.60%	-110.33%	-97.90%	-93.89%	-77.94%	-52.20%	-30.75%	-20.64%
EPS Growth (1Y)	-794.83%	184.64%	-988.82%	-96.65%	-87.66%	-110.29%	-97.91%	-93.91%	-78.03%	-52.39%	-28.78%	-20.11%
Valuation Metrics
P/E TTM	-4.61	-5.60	-6.28	608.29	42.46	-21.09	92.10	28.57	8.14	6.17	7.36	6.80
P/B TTM	0.60	0.57	0.59	0.70	0.71	0.70	0.92	1.01	1.16	1.98	3.63	4.22
P/S TTM	0.37	0.32	0.30	0.35	0.32	0.27	0.32	0.31	0.31	0.47	0.68	0.67
Market Cap	118.14M	112.15M	117.28M	150.25M	154.42M	147.58M	192.59M	209.33M	238.65M	418.03M	731.62M	815.27M
Enterprise Value	46.23M	40.62M	27.97M	50.72M	52.73M	55.86M	101.66M	94.03M	130.63M	320.56M	637.18M	702.52M
Calculated Values
Free Cash Flow TTM	4.01M	-1.47M	1.25M	646.00K	-2.42M	13.47M	17.02M	33.83M	54.40M	84.67M	141.17M	174.27M
Net Debt	-71.91M	-71.53M	-89.30M	-99.53M	-101.69M	-91.72M	-90.93M	-115.31M	-108.02M	-97.47M	-94.44M	-112.75M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-11Purchase

Owner: Schlackman, Scott

Title: -

Shares: 2,500

Price/Share: $12.53

Value: $31,325.00

Shares Owned: 30,549

Relationship: Director

Ownership: Direct

2026-03-20Purchase

Owner: Chard, Daniel R

Title: Chairman & CEO

Shares: 17,678

Price/Share: $10.11

Value: $178,724.58

Shares Owned: 17,678

Relationship: Director,Officer

Ownership: Indirect

2025-06-13Purchase

Owner: Chard, Daniel R

Title: Chairman & CEO

Shares: 381

Price/Share: $13.13

Value: $5,002.53

Shares Owned: 149,698

Relationship: Director,Officer

Ownership: Indirect

2024-03-08Sale

Owner: Schlackman, Scott

Title: -

Shares: 4,053

Price/Share: $39.44

Value: $159,850.32

Shares Owned: 7,785

Relationship: Director

Ownership: Direct

2023-11-07Purchase

Owner: Brown, Jeffrey J

Title: -

Shares: 58

Price/Share: $68.89

Value: $4,019.73

Shares Owned: 5,784

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-11	Schlackman, Scott	Director	-	Direct	Purchase	2,500	12.53	$31,325.00	30,549	4
2026-03-20	Chard, Daniel R	Director,Officer	Chairman & CEO	Indirect	Purchase	17,678	10.11	$178,724.58	17,678	4
2025-06-13	Chard, Daniel R	Director,Officer	Chairman & CEO	Indirect	Purchase	381	13.13	$5,002.53	149,698	4
2024-03-08	Schlackman, Scott	Director	-	Direct	Sale	4,053	39.44	$159,850.32	7,785	4
2023-11-07	Brown, Jeffrey J	Director	-	Direct	Purchase	58	68.89	$4,019.73	5,784	4
2023-11-07	Hoer, Michael A.	Director	-	Direct	Purchase	50	68.89	$3,427.97	8,375	4
2023-11-07	Thomas, Andrea B	Director	-	Direct	Purchase	50	68.89	$3,471.37	6,253	4
2023-11-07	Schlackman, Scott	Director	-	Direct	Purchase	53	68.89	$3,627.06	10,538	4
2023-10-06	Hallquist, Constance J.	Other	-	Indirect	Sale	5,613	73.87	$414,632.31	2,152	4
2023-08-15	Brown, Jeffrey J	Director	-	Indirect	Sale	23,162	90.13	$2,087,591.06	1	4
2023-08-08	Thomas, Andrea B	Director	-	Direct	Purchase	38	89.42	$3,408.69	6,203	4
2023-08-08	Schlackman, Scott	Director	-	Direct	Purchase	40	89.42	$3,560.70	10,485	4
2023-08-08	Brown, Jeffrey J	Director	-	Direct	Purchase	44	89.42	$3,947.00	5,725	4
2023-08-08	Hoer, Michael A.	Director	-	Direct	Purchase	38	89.42	$3,365.77	8,326	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

77.13%

Inst. Shares: 8,488,793

Shares Outstanding: 11,006,000

2025-12-31

71.51%

Inst. Shares: 7,852,103

Shares Outstanding: 10,981,000

2025-09-30

80.03%

Inst. Shares: 8,796,490

Shares Outstanding: 10,991,000

2025-06-30

73.82%

Inst. Shares: 8,113,250

Shares Outstanding: 10,991,000

2025-03-31

71.35%

Inst. Shares: 7,811,725

Shares Outstanding: 10,948,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	8,488,793	11,006,000	77.13%
2025-12-31	7,852,103	10,981,000	71.51%
2025-09-30	8,796,490	10,991,000	80.03%
2025-06-30	8,113,250	10,991,000	73.82%
2025-03-31	7,811,725	10,948,000	71.35%
2024-12-31	8,554,772	10,930,000	78.27%
2024-09-30	8,763,607	10,937,000	80.13%
2024-06-30	9,405,041	10,937,000	85.99%
2024-03-31	10,295,222	10,909,000	94.37%
2023-12-31	9,313,742	10,884,000	85.57%
2023-09-30	8,530,779	10,892,000	78.32%
2023-06-30	8,609,597	10,888,000	79.07%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

MEDIFAST INC (MED) — SEC Financial Statements & Analysis

MEDIFAST INC (MED) is a miscellaneous food preparations & kindred products company, incorporated in DE. MEDIFAST INC trades on NYSE as: MED. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), MEDIFAST INC reported a -34.03% year-over-year revenue growth, a Gross Profit Margin of 69.24% (TTM), a Debt-to-Equity ratio of 0.33x, a Price-to-Sales (P/S) ratio of 0.37x (TTM), a Price-to-Book (P/B) ratio of 0.60x (TTM), at a market cap of $118.14M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -34.03%
Gross Profit Margin TTM: 69.24%
Debt To Equity: 0.33x
P/S TTM: 0.37x
P/B TTM: 0.60x
Market Cap: $118.14M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is MEDIFAST INC in?

MEDIFAST INC (MED) operates in the Miscellaneous Food Preparations & Kindred Products industry.

What is MED's market cap?

MEDIFAST INC (MED) has a market capitalization of $118.14M as of 2026-06-30.

What exchange does MED trade on?

MEDIFAST INC (MED) trades on the NYSE.

Where is MEDIFAST INC incorporated?

MEDIFAST INC is incorporated in DE.

MEDIFAST INC

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

MEDIFAST INC (MED) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Miscellaneous Food Preparations & Kindred Products

Wall Street's data.
Main Street's price.

MEDIFAST INC (MED) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Miscellaneous Food Preparations & Kindred Products

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.